Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean D Sullivan

Showing results (111-120 of 325) with videos related to

Pageof 33
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2026
Spending Impact of the First Ten Drugs Selected for Medicare Drug Price Negotiation in the USYunjoo K Jeon, Ryan N Hansen, Nico Gabriel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2003
Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodineNathorn Chaiyakunapruk, David L Veenstra, Benjamin A Lipsky, et al.
Journal of Managed Care & Specialty Pharmacy|April 25, 2020
The Potential Long-Term Comparative Effectiveness of Larotrectinib and Entrectinib for Second-Line Treatment of TRK Fusion-Positive Metastatic Lung CancerJoshua A Roth, Josh J Carlson, Fang Xia, et al.
Applied Health Economics and Health Policy|August 16, 2014
Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"Josh J Carlson, Katie Gries, Kai Yeung, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2025
The Price Effects of Biosimilars in the United StatesMireia Jofre-Bonet, Alistair McGuire, Victoria Dayer, et al.
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Projecting long-term clinical outcomes with larotrectinib compared with immune checkpoint inhibitors in metastatic nonsmall cell lung cancer and differentiated thyroid cancerKangho Suh, Ashley Kang, Gilbert Ko, et al.
International Journal of Technology Assessment in Health Care|May 8, 2012
Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makersAndres Pichon-Riviere, Federico Augustovski, Sebastián García Martí, et al.
The American Journal of Managed Care|April 13, 2018
Impact of a value-based formulary in three chronic disease cohortsKai Yeung, Anirban Basu, Zachary A Marcum, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
THE AUTHORS RESPONDJoshua A Roth, Josh J Carlson, Fang Xia, et al.
Respiratory Medicine|January 11, 2014
Level of asthma control and health care utilization in Asia-Pacific countriesLaura S Gold, Phillip Thompson, Sundeep Salvi, et al.
Pageof 33

Showing results (111-120 of 325) with videos related to

Sort By:
Pageof 33
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2026
Spending Impact of the First Ten Drugs Selected for Medicare Drug Price Negotiation in the USYunjoo K Jeon, Ryan N Hansen, Nico Gabriel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2003
Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodineNathorn Chaiyakunapruk, David L Veenstra, Benjamin A Lipsky, et al.
Journal of Managed Care & Specialty Pharmacy|April 25, 2020
The Potential Long-Term Comparative Effectiveness of Larotrectinib and Entrectinib for Second-Line Treatment of TRK Fusion-Positive Metastatic Lung CancerJoshua A Roth, Josh J Carlson, Fang Xia, et al.
Applied Health Economics and Health Policy|August 16, 2014
Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"Josh J Carlson, Katie Gries, Kai Yeung, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2025
The Price Effects of Biosimilars in the United StatesMireia Jofre-Bonet, Alistair McGuire, Victoria Dayer, et al.
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Projecting long-term clinical outcomes with larotrectinib compared with immune checkpoint inhibitors in metastatic nonsmall cell lung cancer and differentiated thyroid cancerKangho Suh, Ashley Kang, Gilbert Ko, et al.
International Journal of Technology Assessment in Health Care|May 8, 2012
Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makersAndres Pichon-Riviere, Federico Augustovski, Sebastián García Martí, et al.
The American Journal of Managed Care|April 13, 2018
Impact of a value-based formulary in three chronic disease cohortsKai Yeung, Anirban Basu, Zachary A Marcum, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
THE AUTHORS RESPONDJoshua A Roth, Josh J Carlson, Fang Xia, et al.
Respiratory Medicine|January 11, 2014
Level of asthma control and health care utilization in Asia-Pacific countriesLaura S Gold, Phillip Thompson, Sundeep Salvi, et al.
Pageof 33